spin

11th Asia Regulatory Conference

17-21 October 2022

Date

17-21 October

Platform

Virtual Zoom Meeting

Conference Schedule

Conference Program
07:30

Regulatory Agilities

Regulatory agilities and further accelerating patient access to safe and effective medicines and vaccines
  
08:00

Post Approval Changes

Reliance, Convergence/Harmonization and Risk Based Approaches to PACs
  
08:00

Quality

Delivering products with the same quality standards to patients everywhere
  
08:00

ICH

ICH – The Foundations of Success
  
08:00

Biotherapeutics & Advanced Therapies

Changing regulatory landscape of Biotherapeutics and Cell & Gene Therapies
  

Program Committee

Janis Bernat

Director, Scientific & Regulatory Affairs IFPMA

Sergio Cavalheiro Filho

Manager, Regulatory Affairs, IFPMA

Mümün Gencoglu

Manager, Regulatory Affairs IFPMA (more…)

Sarah Adam

Associate Director, Regulatory Affairs IFPMA (more…)

Greg Perry

Assistant Director General IFPMA   (more…)

Advisory Board

Sannie Chong

Asia Pacific Technical Regulatory Policy Roche Singapore Technical Operations

Dr Julie O’Brien

Director, Global Regulatory Policy Pfizer

Céline Bourguinon

Head Greater China and Intercontinental & Emerging Markets Regulatory Policy GSK

Janis Bernat

Director, Scientific & Regulatory Affairs IFPMA

Adam Hacker

Director and Head of Global Regulatory Affairs CEPI

John Lim

Executive Director, Duke-NUS Senior Advisor, MOH

Kum Cheun Wong

Head Asia Pacific Regulatory & Development Policy Novartis

Samvel Azatyan

Group Lead, Regulatory Convergence and Networks Team, WHO

Runyi Mo

Associate Director of Global Regulatory Science and Policy, China Team Sanofi

Warren Beck

AVP Regulatory Affairs Lead Asia Pacific MSD

Dinesh Khokal

Director, Quality External Affairs - JAPAC Amgen

Anita Abu Bakar

President of MIASA Malaysia & Chairman of the National Advocacy of

Speakers